In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q2 2023, worth a total value of $129.2m, according to GlobalData’s Deals Database. The $100m acquisition of dia imaging analysis by philips healthcare uk was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in Middle East and Africa increased by 9% in Q2 2023 compared with the previous quarter’s total of $118.1m and fell by 76% as compared to Q2 2022. Related deal volume decreased by 30% in Q2 2023 versus the previous quarter and was 133% higher than in Q2 2022.
For further understanding of GlobalData's Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.